Clinical Trial Update: Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing Danhong Injection for benefits and mechanisms in modulating mitochondrial homeostasis to counter sepsis-associated myoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis-associated Myocardial Dysfunction

Drugs mentioned

• Danhong Injection

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Sepsis-Induced Myocardial Dysfunction | Phase 2 | Status: NOT_YET_RECRUITING